Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Medivation Inc    MDVN

SummaryQuotesNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Medivation Inc : Medivation Announces Participation at Upcoming Investor Conferences

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/30/2013 | 10:34pm CET

SAN FRANCISCO, CA -- (Marketwired) -- 10/28/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a live teleconference with management to discuss third quarter 2013 financial results and provide a general business update on November 12, 2013 at 4:30 p.m. Eastern Time. A press release for the third quarter of 2013 will be released after markets close on November 12, 2013.

Interested parties may listen to the live teleconference by calling 877-303-2523 from the U.S. or +1-253-237-1755 internationally. Individuals may access the live audio webcast by visiting: http://investors.medivation.com/events.cfm.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.

Contacts:
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101

Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900

Source: Medivation

News Provided by Acquire Media

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEDIVATION INC
2016 Drugmaker Sanofi hungry for deals after earnings beat
2016 MEDIVATION : New Data Presented at ESMO 2016 Further Demonstrates XTANDITM▼..
2016 PFIZER : Completes Acquisition of Medivation
2016 MEDIVATION, INC. : Termination of a Material Definitive Agreement, Completion of..
2016 PFIZER INC. (NYSE : PFE) Acquisition Of Medivation, Inc. (NASDAQ:MDVN) To Close ..
2016 Xenon Pharmaceuticals Appoints Dawn Svoronos to Its Board of Directors
2016 MEDIVATION : Highlights New Data From Differentiated Oncology Portfolio at ESMO ..
2016 PFIZER : Announces Expiration of HSR Waiting Period For Proposed Acquisition of ..
2016DJPfizer Throws Out Plan to Split Into Two Companies
2016 PFIZER : expects to close Medivation buyout in 3Q
More news
Sector news : Bio Therapeutic Drugs
03/18DJAMGEN : Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 3rd Update
03/17DJAMGEN : Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 2nd Update
03/17DJAMGEN : Money-Back Guarantee
03/17DJAmgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- Update
03/17DJAmgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
03/06 BIOTECH FORUM DAILY DIGEST : Biotech Closes Above Resistance Levels. Icahn Getti..
02/10 BIOTECH FORUM DAILY DIGEST : Buyout Rumors On The Rise; Aratana Therapeutics' De..
02/03 Pfizer May Be Another IBM
2016 M&A Gives Signs Of Reverting To The Mean
2016 Pfizer's Growth Strategies May Need More Than Just Small Acquisitions
Advertisement
Financials ($)
More Financials
Technical analysis trends MEDIVATION INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus 
Mean consensus
Number of Analysts
Average target price -
Spread / Average Target
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David T. Hung President, Chief Executive Officer & Director
Kim D. Blickenstaff Chairman
Marion McCourt Chief Operating Officer
Jennifer Jarrett Chief Financial Officer
Mohammad Hirmand Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MEDIVATION INC0.00%0
AMGEN, INC.13.56%122 281
CELGENE CORPORATION6.45%95 861
GILEAD SCIENCES, INC.-5.75%88 214
REGENERON PHARMACEUTIC..-0.56%38 722
ACTELION LTD24.72%29 697
More Results